BiotechTube
Home/Neurovation Labs/Jennifer N. Perusini, Ph.D.
JN

Jennifer N. Perusini, Ph.D.

Chief Executive Officer

Neurovation Labs

Therapeutic Areas

PsychiatryNeurology

Neurovation Labs Pipeline

DrugIndicationPhase
Amygdala-specific AMPA receptor NAMPTSD (with secondary indications for aggression and impulsivity)Preclinical

Leadership Team at Neurovation Labs

MS
Michael S. Fanselow, Ph.D.
Director of Research
RP
Richard P. Zemsky
Chief Operating Officer/Legal
View full Neurovation Labs profile